HK1258801A1 - 穩定的蘿蔔硫素 - Google Patents

穩定的蘿蔔硫素

Info

Publication number
HK1258801A1
HK1258801A1 HK19101165.6A HK19101165A HK1258801A1 HK 1258801 A1 HK1258801 A1 HK 1258801A1 HK 19101165 A HK19101165 A HK 19101165A HK 1258801 A1 HK1258801 A1 HK 1258801A1
Authority
HK
Hong Kong
Prior art keywords
stabilized sulforaphane
sulforaphane
stabilized
Prior art date
Application number
HK19101165.6A
Other languages
English (en)
Inventor
Ido Dov Dagan
Albert Roger Frisbee
Peter Wyatt Newsome
Michel Pierre Baudet
Original Assignee
Pharmagra Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39641899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1258801(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmagra Labs Inc filed Critical Pharmagra Labs Inc
Publication of HK1258801A1 publication Critical patent/HK1258801A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16—Isothiocyanates
    • C07C331/18—Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms
    • C07C331/20—Isothiocyanates having isothiocyanate groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16—Isothiocyanates
    • C07C331/26—Isothiocyanates having isothiocyanate groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/025—Purification; Separation; Stabilisation; Desodorisation of organo-phosphorus compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/16—Cyclodextrin; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
HK19101165.6A 2007-01-23 2019-01-23 穩定的蘿蔔硫素 HK1258801A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88187507P 2007-01-23 2007-01-23

Publications (1)

Publication Number Publication Date
HK1258801A1 true HK1258801A1 (zh) 2019-11-22

Family

ID=39641899

Family Applications (2)

Application Number Title Priority Date Filing Date
HK14113030.9A HK1199407A1 (zh) 2007-01-23 2014-12-29 穩定化之蘿蔔硫素
HK19101165.6A HK1258801A1 (zh) 2007-01-23 2019-01-23 穩定的蘿蔔硫素

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK14113030.9A HK1199407A1 (zh) 2007-01-23 2014-12-29 穩定化之蘿蔔硫素

Country Status (17)

Country Link
US (1) US7879822B2 (zh)
EP (4) EP3354267B1 (zh)
JP (4) JP2010516766A (zh)
AU (1) AU2008209543B2 (zh)
CA (1) CA2672971C (zh)
CY (1) CY1122136T1 (zh)
DK (2) DK3354267T3 (zh)
ES (2) ES2743043T3 (zh)
HK (2) HK1199407A1 (zh)
HR (1) HRP20191495T1 (zh)
HU (2) HUE046151T2 (zh)
LT (1) LT3354267T (zh)
PL (2) PL3354267T3 (zh)
PT (1) PT3354267T (zh)
SI (1) SI3354267T1 (zh)
TR (1) TR201808561T4 (zh)
WO (1) WO2008091608A1 (zh)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3354267T (lt) * 2007-01-23 2019-09-25 Pharmagra Labs, Inc. Stabilizuotas sulforafanas
WO2010065329A2 (en) * 2008-11-25 2010-06-10 The Board Of Regents Of The University Of Texas System Nanoparticles for cancer treatment
BE1019434A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Stabilisation du sulforaphane.
US11407713B2 (en) 2011-01-03 2022-08-09 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10640464B2 (en) 2011-01-03 2020-05-05 The William M. Yarbrough Foundation Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
US8933119B2 (en) 2011-01-03 2015-01-13 The William M. Yarbrough Foundation Method for treating phytophotodermatitis
US10308599B2 (en) 2011-01-03 2019-06-04 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10647668B2 (en) 2011-01-03 2020-05-12 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US11279674B2 (en) 2011-01-03 2022-03-22 The William M. Yarbrough Foundation Isothiocyanate functional surfactant and associated method of use
US9962361B2 (en) 2011-01-03 2018-05-08 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
US10273205B2 (en) 2011-01-03 2019-04-30 The William M. Yarbrough Foundation Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
US8865765B2 (en) 2011-01-12 2014-10-21 The William M. Yarbrough Foundation Method for treating eczema
US9532969B2 (en) 2011-02-08 2017-01-03 The William M. Yarbrough Foundation Method for treating psoriasis
WO2012116018A1 (en) 2011-02-22 2012-08-30 Caudill Seed Company, Inc. Spray dried myrosinase and use to produce isothiocyanates
ES2425294B1 (es) * 2012-03-09 2014-09-02 Consejo Superior De Investigaciones Científicas (Csic) Compuestos derivados de sulforafano, método de obtención y su uso médico, alimenticio y cosmético
CN102697764A (zh) * 2012-05-03 2012-10-03 苏州纳晶医药技术有限公司 一种含有异硫氰酸苯乙酯的肠溶固体制剂
EP2854862B1 (en) * 2012-06-01 2018-08-01 Pharmagra Labs, Inc. Sulforaphane isolation and purification
CN104703628B (zh) * 2012-06-01 2017-09-08 法玛格拉实验室公司 合成萝卜硫烷的方法
WO2014018874A1 (en) 2012-07-26 2014-01-30 The William M. Yarbrough Foundation Method for treating skin cancer
US9839621B2 (en) 2012-07-26 2017-12-12 The William M. Yarbrough Foundation Method for treating bladder cancer
US10434081B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Inhibitors of macrophage migration inhibitory factor
US10441561B2 (en) 2012-07-26 2019-10-15 The William M. Yanbrough Foundation Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
US10080734B2 (en) 2012-07-26 2018-09-25 The William M. Yarbrough Foundation Method for treating autism and other neurodevelopmental disorders
US9949943B2 (en) 2012-07-26 2018-04-24 The William M. Yarbrough Foundation Method for treating neurodegenerative diseases
US10434082B2 (en) 2012-07-26 2019-10-08 The William M. Yarbrough Foundation Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
US10335387B2 (en) 2012-07-26 2019-07-02 The William M. Yarbrough Foundation Method for treating infectious diseases with isothiocyanate functional compounds
DE102014012367B3 (de) * 2014-08-25 2015-08-27 De Smaakmaker Holding B. V. Verfahren zum Bestimmen der Konzentration von Glucoraphanin und/oder von Sulforaphan in einer Pflanze
CN107468666B (zh) * 2017-08-18 2021-01-01 赣州华汉生物科技有限公司 一种可稳定保存的萝卜硫素胶囊及其制备方法
US20210100751A1 (en) * 2018-02-02 2021-04-08 Commonwealth Scientific and Industral Research Organisation Protecting a bioactive and/or precursor thereof
GB2574248B (en) * 2018-05-31 2021-03-03 Edwards Ltd Foreline for a vacuum pump
KR102457241B1 (ko) * 2020-02-26 2022-10-21 경일대학교산학협력단 페닐이소티오시아네이트를 처리하여 십자화과 식물로부터 설포라판을 생산하는 방법 및 보존하는 방법
GB202005238D0 (en) 2020-04-08 2020-05-20 Evgen Pharma Plc Crystalline complexes
CA3175531A1 (en) 2020-04-23 2021-10-28 V. Theocharis KOFTIS Compositions for stabilizing an isothiocyanate
WO2023037934A1 (ja) * 2021-09-13 2023-03-16 富士フイルム株式会社 ビシクロアルカン化合物の包摂体の製造方法
CN113908294B (zh) * 2021-11-02 2023-09-12 成都格纯生物医药有限公司 一种含花椰菜精制提取物的双包合物的制备方法和应用
WO2023133494A2 (en) * 2022-01-06 2023-07-13 Brassica Protection Products Llc Oil-based isothiocyanate products and processes for preparing oil-based isothiocyanate products

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US669984A (en) * 1900-02-06 1901-03-19 Josef Federmann Spittoon.
US673744A (en) * 1900-08-06 1901-05-07 Pearl M Westerfield Vending-box.
US5458903A (en) * 1993-01-19 1995-10-17 The Pillsbury Company High fat biscuit mix and products resulting therefrom
US5411986A (en) 1993-03-12 1995-05-02 The Johns Hopkins University Chemoprotective isothiocyanates
JP3604172B2 (ja) * 1994-03-22 2004-12-22 株式会社白元 除菌組成物、及び除菌方法
US5589504A (en) 1994-07-26 1996-12-31 Cornell Research Foundation, Inc. Treatment of newborn jaundice
AU8779898A (en) 1997-08-11 1999-03-01 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
US6699849B1 (en) 1998-02-23 2004-03-02 Cyclops, Ehf. Cyclodextrin complexes of benzodiazepines
FR2776666B1 (fr) * 1998-03-31 2002-09-06 Commissariat Energie Atomique Complexes d'inclusion dans des cyclodextrines d'isothiocyanates organiques, en particulier bacteriostatiques, bactericides et/ou fongicides ou de leurs precurseurs naturels, et leur preparation
US6048736A (en) * 1998-04-29 2000-04-11 Kosak; Kenneth M. Cyclodextrin polymers for carrying and releasing drugs
AU5535900A (en) 1999-07-01 2001-01-22 Italfarmaco S.P.A. Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives
US6361812B1 (en) 1999-11-18 2002-03-26 The Procter & Gamble Co. Products comprising an isothiocyanate preservative system and methods of their use
US20030091518A1 (en) * 1999-12-20 2003-05-15 Gilles Pauly Cosmetic and/or pharmaceutical preparations
US6433011B1 (en) 2000-03-08 2002-08-13 American Health Foundation Method for inhibiting formation of aberrant crypt foci in the colon of a mammal
US6511675B2 (en) 2000-06-12 2003-01-28 Access Business Group International, Llc Composition and method for correcting a dietary phytochemical deficiency
WO2002002190A2 (en) 2000-07-05 2002-01-10 Johns Hopkins School Of Medicine Prevention and treatment of neurodegenerative diseases by glutathione and phase ii detoxification enzymes
JP5132865B2 (ja) * 2000-08-21 2013-01-30 ジェド ダブリュ． ファーヒー イソチオシアネートを用いたヘリコバクターの治療方法
JP2002187842A (ja) * 2000-12-19 2002-07-05 Toyo Shinyaku:Kk ケール加工品およびその加工方法
JP2003146803A (ja) * 2001-11-13 2003-05-21 Carex Inc 抗菌性粉末組成物およびその製造方法
CA2603235A1 (en) * 2005-03-28 2006-10-05 Bioresponse, Llc Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health
FR2888235B1 (fr) * 2005-07-07 2007-09-14 Nutrinov Sa Procede d'extraction de sulforaphane a partir de broyat de crucifere contenant de la glucoraphanine
CN101120948A (zh) * 2006-08-08 2008-02-13 普文英 一种具有化学保护、癌症预防和治疗用途的化合物组合物
LT3354267T (lt) * 2007-01-23 2019-09-25 Pharmagra Labs, Inc. Stabilizuotas sulforafanas

Also Published As

Publication number Publication date
AU2008209543A1 (en) 2008-07-31
JP6677688B2 (ja) 2020-04-08
CA2672971A1 (en) 2008-07-31
EP2120969A1 (en) 2009-11-25
WO2008091608A1 (en) 2008-07-31
JP2018027956A (ja) 2018-02-22
JP2010516766A (ja) 2010-05-20
US7879822B2 (en) 2011-02-01
JP2016145218A (ja) 2016-08-12
JP6566886B2 (ja) 2019-08-28
HK1199407A1 (zh) 2015-07-03
EP2532352A1 (en) 2012-12-12
ES2674052T3 (es) 2018-06-27
LT3354267T (lt) 2019-09-25
DK3354267T3 (da) 2019-08-26
US20080176942A1 (en) 2008-07-24
EP3354267A1 (en) 2018-08-01
AU2008209543B2 (en) 2014-03-13
PT3354267T (pt) 2019-09-10
EP3354267B1 (en) 2019-08-07
TR201808561T4 (tr) 2018-07-23
HUE046151T2 (hu) 2020-02-28
PL2796140T3 (pl) 2018-09-28
JP2014055140A (ja) 2014-03-27
HRP20191495T1 (hr) 2019-11-29
PL3354267T3 (pl) 2019-11-29
CA2672971C (en) 2014-03-11
EP2796140A2 (en) 2014-10-29
CY1122136T1 (el) 2020-11-25
DK2796140T3 (en) 2018-06-25
EP2796140A3 (en) 2014-12-24
EP2120969A4 (en) 2010-06-02
EP2796140B1 (en) 2018-05-02
HUE039549T2 (hu) 2019-01-28
SI3354267T1 (sl) 2019-11-29
ES2743043T3 (es) 2020-02-18

Similar Documents

Publication Publication Date Title
HK1258801A1 (zh) 穩定的蘿蔔硫素
EP2212908A4 (en) JUNCTION FIELD EFFECT TRANSISTOR WITH AILET
DE602008005470D1 (en) Imidazopyridinone
EP2160187A4 (en) SPIROINDALONE
AP2010005314A0 (en) Nanodispersian
EP2211752A4 (en) BIOPULPA
DK2135129T3 (en) Midler til hurtigfastgørelse til brillestang
GB2463219B (en) Fixing
GB0718708D0 (en) Improved fitting
GB2452302B (en) Fixing
KG1098C1 (en) Towel-drying construction
DE602008004135D1 (en) Triphenylmethan- und xanthenpigmente
GB0720292D0 (en) Equation solving
AU3613P (en) LS005A01 Leucospermum cuneiforme
AU3952P (en) FLOCHRDEF Chrysocephalum apiculatum
AU3606P (en) Jaywick xTriticosecale
AU3642P (en) TAS100 Dianella tasmanica
AU3595P (en) Goldust Strobilanthes anisophyllus
ZA200905054B (en) Construction set
GB0717492D0 (en) Turn case
GB0700193D0 (en) Plug-guard
AU317582S (en) Rainhead
GB0700085D0 (en) Multi-cleanser
AU2007247V (en) CalredGL Calothamnus quadrifidus
AU314580S (en) Rangehood